We've found
6,916 Ovarian Cancer
clinical trials
We've found
6,916 Ovarian Cancer
clinical trials
Oncology, Psychiatry / Psychology Clinical Trial
Updated: 8/22/2017
Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
III
Updated: 8/22/2017
Click here to add this to my saved trials

Oncology, Psychiatry / Psychology Clinical Trial
Updated: 8/22/2017
Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
III
Updated: 8/22/2017
Click here to add this to my saved trials

Oncology, Psychiatry / Psychology Clinical Trial
Updated: 8/22/2017
Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
III
Updated: 8/22/2017
Click here to add this to my saved trials

Oncology, Psychiatry / Psychology Clinical Trial
Updated: 8/22/2017
Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
III
Updated: 8/22/2017
Click here to add this to my saved trials

Oncology, Psychiatry / Psychology Clinical Trial
Updated: 8/22/2017
Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
III
Updated: 8/22/2017
Click here to add this to my saved trials

Oncology, Psychiatry / Psychology Clinical Trial
Updated: 8/22/2017
Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
III
Updated: 8/22/2017
Click here to add this to my saved trials

Oncology, Psychiatry / Psychology Clinical Trial
Updated: 8/22/2017
Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
III
Updated: 8/22/2017
Click here to add this to my saved trials

Oncology, Psychiatry / Psychology Clinical Trial
Updated: 8/22/2017
Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
III
Updated: 8/22/2017
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Cancer Screening and Prevention Program for High Risk Women
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Cancer Screening and Prevention Program for High Risk Women
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 2/16/2012
MK-2206 in the Treatment of Recurrent Platinum-Resistant Ovarian, Fallopian Tube, or Peritoneal Cancer
Status: Enrolling
Updated: 2/16/2012
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 2/16/2012
MK-2206 in the Treatment of Recurrent Platinum-Resistant Ovarian, Fallopian Tube, or Peritoneal Cancer
Status: Enrolling
Updated: 2/16/2012
Click here to add this to my saved trials

Endocrinology, Oncology, Reproductive Clinical Trial
Updated: 1/18/2018
Etiological Factors of Obesity-Associated Hyperandrogenemia in Peripubertal Girls
Status: Enrolling
Updated: 1/18/2018
Click here to add this to my saved trials

Ovarian Cancer Clinical Trial
Updated: 4/17/2014
Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)
Status: Enrolling,
Phase
III
Updated: 4/17/2014
Click here to add this to my saved trials

Ovarian Cancer Clinical Trial
Updated: 4/17/2014
Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)
Status: Enrolling,
Phase
III
Updated: 4/17/2014
Click here to add this to my saved trials

Ovarian Cancer Clinical Trial
Updated: 4/17/2014
Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)
Status: Enrolling,
Phase
III
Updated: 4/17/2014
Click here to add this to my saved trials

Ovarian Cancer Clinical Trial
Updated: 4/17/2014
Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)
Status: Enrolling,
Phase
III
Updated: 4/17/2014
Click here to add this to my saved trials

Ovarian Cancer Clinical Trial
Updated: 4/17/2014
Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)
Status: Enrolling,
Phase
III
Updated: 4/17/2014
Click here to add this to my saved trials

Ovarian Cancer Clinical Trial
Updated: 4/17/2014
Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)
Status: Enrolling,
Phase
III
Updated: 4/17/2014
Click here to add this to my saved trials

Ovarian Cancer Clinical Trial
Updated: 4/17/2014
Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)
Status: Enrolling,
Phase
III
Updated: 4/17/2014
Click here to add this to my saved trials

Ovarian Cancer Clinical Trial
Updated: 4/17/2014
Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)
Status: Enrolling,
Phase
III
Updated: 4/17/2014
Click here to add this to my saved trials

Ovarian Cancer Clinical Trial
Updated: 4/17/2014
Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)
Status: Enrolling,
Phase
III
Updated: 4/17/2014
Click here to add this to my saved trials

Ovarian Cancer Clinical Trial
Updated: 4/17/2014
Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)
Status: Enrolling,
Phase
III
Updated: 4/17/2014
Click here to add this to my saved trials

Ovarian Cancer Clinical Trial
Updated: 4/17/2014
Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)
Status: Enrolling,
Phase
III
Updated: 4/17/2014
Click here to add this to my saved trials

Ovarian Cancer Clinical Trial
Updated: 4/17/2014
Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)
Status: Enrolling,
Phase
III
Updated: 4/17/2014
Click here to add this to my saved trials

Ovarian Cancer Clinical Trial
Updated: 4/17/2014
Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)
Status: Enrolling,
Phase
III
Updated: 4/17/2014
Click here to add this to my saved trials

Ovarian Cancer Clinical Trial
Updated: 4/17/2014
Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)
Status: Enrolling,
Phase
III
Updated: 4/17/2014
Click here to add this to my saved trials

Ovarian Cancer Clinical Trial
Updated: 4/17/2014
Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)
Status: Enrolling,
Phase
III
Updated: 4/17/2014
Click here to add this to my saved trials

Ovarian Cancer Clinical Trial
Updated: 4/17/2014
Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)
Status: Enrolling,
Phase
III
Updated: 4/17/2014
Click here to add this to my saved trials

Ovarian Cancer Clinical Trial
Updated: 4/17/2014
Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)
Status: Enrolling,
Phase
III
Updated: 4/17/2014
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 6/15/2012
VTX-2337 and Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer
Status: Enrolling
Updated: 6/15/2012
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/3/2012
Alvocidib and Oxaliplatin With or Without Fluorouracil and Leucovorin Calcium in Treating Patients With Relapsed or Refractory Germ Cell Tumors
Status: Enrolling
Updated: 12/3/2012
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 3/4/2013
SJG-136 in Treating Patients With Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer That Did Not Respond to Previous Treatment With Cisplatin or Carboplatin
Status: Enrolling
Updated: 3/4/2013
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 3/11/2014
Safety Study of ²¹²Pb-TCMC-Trastuzumab Radio Immunotherapy
Status: Enrolling,
Phase
I
Updated: 3/11/2014
Click here to add this to my saved trials

Oncology, Ophthalmology, Other Clinical Trial
Updated: 12/31/1969
DICER1-related Pleuropulmonary Blastoma Cancer Predisposition Syndrome: A Natural History Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 9/27/2017
Body Warming in Improving Blood Flow and Oxygen Delivery to Tumors in Patients With Cancer
Status: Enrolling
Updated: 9/27/2017
Click here to add this to my saved trials

Polycystic Ovary Syndrome Clinical Trial
Updated: 2/24/2016
Evaluation of Oral Lipid Ingestion in Relation to Ovarian Androgen Secretion in Polycystic Ovary Syndrome (PCOS)
Status: Enrolling
Updated: 2/24/2016
Click here to add this to my saved trials

Immunology / Infectious Diseases, Oncology Clinical Trial
Updated: 12/31/1969
Outcomes After Secondary Cytoreductive Surgery With or Without Carboplatin Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Followed by Systemic Combination Chemotherapy for Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Immunology / Infectious Diseases, Oncology Clinical Trial
Updated: 12/31/1969
Outcomes After Secondary Cytoreductive Surgery With or Without Carboplatin Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Followed by Systemic Combination Chemotherapy for Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Ovarian Cancer Clinical Trial
Updated: 9/9/2013
Phase I/Ib Study of Paclitaxel in Combination With VS-6063 in Patients With Advanced Ovarian Cancer
Status: Enrolling,
Phase
I
Updated: 9/9/2013
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 1/30/2015
Palifosfamide in Treating Patients With Recurrent Germ Cell Tumors
Status: Enrolling,
Phase
II
Updated: 1/30/2015
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 1/30/2015
Palifosfamide in Treating Patients With Recurrent Germ Cell Tumors
Status: Enrolling,
Phase
II
Updated: 1/30/2015
Click here to add this to my saved trials

Epithelial Ovarian Cancer Clinical Trial
Updated: 10/21/2014
Cvac as Maintenance Treatment in Patients With EOC in Complete Remission Following First-Line Chemotherapy or Second-Line Treatment
Status: Enrolling,
Phase
II
Updated: 10/21/2014
Click here to add this to my saved trials

Epithelial Ovarian Cancer Clinical Trial
Updated: 10/21/2014
Cvac as Maintenance Treatment in Patients With EOC in Complete Remission Following First-Line Chemotherapy or Second-Line Treatment
Status: Enrolling,
Phase
II
Updated: 10/21/2014
Click here to add this to my saved trials

Epithelial Ovarian Cancer Clinical Trial
Updated: 10/21/2014
Cvac as Maintenance Treatment in Patients With EOC in Complete Remission Following First-Line Chemotherapy or Second-Line Treatment
Status: Enrolling,
Phase
II
Updated: 10/21/2014
Click here to add this to my saved trials

Epithelial Ovarian Cancer Clinical Trial
Updated: 10/21/2014
Cvac as Maintenance Treatment in Patients With EOC in Complete Remission Following First-Line Chemotherapy or Second-Line Treatment
Status: Enrolling,
Phase
II
Updated: 10/21/2014
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Acute Normovolemic Hemodilution in Patients Undergoing Cytoreductive Surgery for Advanced Ovarian Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Acute Normovolemic Hemodilution in Patients Undergoing Cytoreductive Surgery for Advanced Ovarian Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Updated: 12/31/1969
Integrated Cancer Repository for Cancer Research
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Updated: 12/31/1969
Integrated Cancer Repository for Cancer Research
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Updated: 12/31/1969
Integrated Cancer Repository for Cancer Research
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Updated: 12/31/1969
Integrated Cancer Repository for Cancer Research
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Updated: 12/31/1969
Integrated Cancer Repository for Cancer Research
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Updated: 12/31/1969
Integrated Cancer Repository for Cancer Research
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Updated: 12/31/1969
Integrated Cancer Repository for Cancer Research
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Updated: 12/31/1969
Integrated Cancer Repository for Cancer Research
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Updated: 12/31/1969
Integrated Cancer Repository for Cancer Research
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Updated: 12/31/1969
Integrated Cancer Repository for Cancer Research
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Updated: 12/31/1969
Integrated Cancer Repository for Cancer Research
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Updated: 12/31/1969
Integrated Cancer Repository for Cancer Research
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Updated: 12/31/1969
Integrated Cancer Repository for Cancer Research
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Updated: 12/31/1969
Integrated Cancer Repository for Cancer Research
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Updated: 12/31/1969
Integrated Cancer Repository for Cancer Research
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Updated: 12/31/1969
Integrated Cancer Repository for Cancer Research
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab in Treating Patients With Stage IV Melanoma That Cannot Be Removed by Surgery or Gynecological Cancers
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
DEC-205/NY-ESO-1 Fusion Protein CDX-1401, Poly ICLC, and IDO1 Inhibitor INCB024360 in Treating Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Remission
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Pembrolizumab and Ziv-aflibercept in Treating Patients With Advanced Solid Tumors
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Avatar-Directed Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Ovarian Cancer Clinical Trial
Updated: 3/15/2016
DOD Long-Term Survivors of Ovarian Cancer
Status: Enrolling
Updated: 3/15/2016
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Selective Inhibitor of Nuclear Export, Selinexor (KPT-330) in Combination With Paclitaxel and Carboplatin in Patients With Advanced Ovarian or Endometrial Cancers
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Advanced Cancers Clinical Trial
Updated: 12/31/1969
Study of the PARP Inhibitor BMN 673 in Advanced Cancer Patients With Somatic Alterations in BRCA1/2, Mutations/Deletions in PTEN or PTEN Loss, a Homologous Recombination Defect, Mutations/Deletions in Other BRCA Pathway Genes and Germline Mutation in BRCA1/2 (Not Breast or Ovarian Cancer)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
